leadf
logo-loader
viewOxford BioDynamics PLC
(
AIM:OBDFRA:LMQ
)

'Interest is growing exponentially', says Oxford Biodynamics' Christian Hoyer Millar

Oxford Biodynamics (LON:OBD) CEO Christian Hoyer Millar and CSO Sasha Akoulitchev talk to Proactive's Andrew Scott about the company's platform EpiSwitch as well as the overall strategy and outlook.

Their technology manages biomarkers in people’s blood to help pharmaceutical companies identify which patients will react to certain drugs.

''We've worked with six of the biggest pharma and biotech companies in the world so far. We've undertaken about 23 projects and the interest in what we're doing is growing exponentially'', Hoyer Millar says.

Quick facts: Oxford BioDynamics PLC

Follow
AIM:OBD

Price: 46.5 GBX

Market Cap: £43.04 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Hochschild Mining reveals 'profitable' PEA on its heavy rare earths project...

Hochschild Mining Head of Investor Relations Charles Gordon joined Proactive New York to discuss the Peru-based gold and silver miner's recent developments within its heavy rare earths project, recently renamed Aclara. Gordon says the group recently revealed a preliminary economic assessment...

2 days, 9 hours ago

2 min read